Mehtap Aydın
-
- Antibiotic Use and Resistance 9
- Geriatrics and Gerontology top 10%
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 12
- SARS-CoV-2 and COVID-19 Research 5
- Antifungal resistance and susceptibility 4
- General Dentistry top 10%
-
- Pneumonia and Respiratory Infections 4
-
- Long-Term Effects of COVID-19 5
-
- Hepatitis C virus research 4
-
- Genomics, phytochemicals, and oxidative stress 3
Mehtap Aydın
50 papers receiving 528 citations
Peers
Comparison fields: 5 of 108
- Applied Microbiology and Biotechnology 58
- Geriatrics and Gerontology 38
- Infectious Diseases 152
- General Dentistry 12
- Epidemiology 156
Countries citing papers authored by Mehtap Aydın
This map shows the geographic impact of Mehtap Aydın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehtap Aydın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehtap Aydın more than expected).
Fields of papers citing papers by Mehtap Aydın
This network shows the impact of papers produced by Mehtap Aydın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehtap Aydın. The network helps show where Mehtap Aydın may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mehtap Aydın, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 11 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 3 | |
| 12 | 2020 | 23 | |
| 13 | 2017 | 30 | |
| 14 | 2016 | 42 | |
| 15 | 2016 | 3 | |
| 16 | 2014 | 3 | |
| 17 | 2010 | 3 | |
| 18 | The cytological evaluation of bladder and lung carcinoma rates on the workers exposed to industrial chemicals. | 2009 | 2 |
| 19 | 2008 | 41 | |
| 20 | Tavşanlarda intraabdominal adezyonların önlenmesinde fluniksin meglumine ve mepiramin maleatin etkileri üzerine deneysel araştırma | 2007 | 1 |
About Mehtap Aydın
Mehtap Aydın is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Microbiology, having authored 54 papers that have together received 544 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (12 papers), Antibiotic Use and Resistance (9 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Long-Term Effects of COVID-19 (5 papers), Pneumonia and Respiratory Infections (4 papers), Antifungal resistance and susceptibility (4 papers), Hepatitis C virus research (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (58 citations), Geriatrics and Gerontology (38 citations) and Infectious Diseases (152 citations). Mehtap Aydın has collaborated with scholars based in Türkiye, United Kingdom and Kuwait. Frequent co-authors include Funda Demirağ, Ebru Çakır, Ebru Ünsal, Sevtap Aydın, Merve Bacanlı, Ahmet Akıcı, Hüseyin Tombuloğlu, Nurşen Başaran, Arif Ahmet Başaran and Tevfik Tolga Şahin. Their work appears in journals such as PLoS ONE, Advanced Science and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.